Unum Therapeutics

Unum Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products aimed at harnessing the power of the patient’s immune system to cure cancer. The proprietary technology, called Antibody-Coupled T Cell Receptor (ACTR), is a universal engineered cell therapy designed to be used in combination with a wide range of tumor-specific antibodies to target different tumor types.